351369-12-5 Usage
Uses
Used in Chemical Research:
Carbamic acid, (4-fluoro-3-pyrrolidinyl)-, 1,1-dimethylethyl ester (9CI) is used as a research compound for exploring its chemical properties and reactivity in various chemical reactions. Its unique structure allows for the investigation of its potential interactions with other molecules and its role in chemical synthesis.
Used in Pharmaceutical Manufacturing:
In the pharmaceutical industry, Carbamic acid, (4-fluoro-3-pyrrolidinyl)-, 1,1-dimethylethyl ester (9CI) is used as an intermediate or building block in the synthesis of various pharmaceutical compounds. Its carbamate functional group and the presence of a fluorine atom in the pyrrolidinyl ring make it a valuable component in the development of new drugs with specific therapeutic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 351369-12-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,3,6 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 351369-12:
(8*3)+(7*5)+(6*1)+(5*3)+(4*6)+(3*9)+(2*1)+(1*2)=135
135 % 10 = 5
So 351369-12-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H17FN2O2/c1-9(2,3)14-8(13)12-7-5-11-4-6(7)10/h6-7,11H,4-5H2,1-3H3,(H,12,13)
351369-12-5Relevant articles and documents
Quinolizinone type compounds
-
, (2008/06/13)
Antibacterial compounds having the formula STR1 and the pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those compounds wherein A is =CR6 --; R1 is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R2 is selected from the group consisting of STR2 R3 is halogen; R4 is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R5 is hydrogen, loweralkyl, halo(loweralkyl), or --NR13 R14 ; and R6 is halogen, loweralkyl, halo(loweralkyl), hydroxy-substituted loweralkyl, loweralkoxy(loweralkyl), loweralkoxy, or amino(loweralkyl), as well as pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
